title: Stem cell mediated cardiovascular repair.
abstract: Recent increase in the interest in stem and progenitor cells may be attributed to their behavioural characteristics. A consensus has been reached that embryonic or adult stem cells have therapeutic potential. As cardiovascular health issues are still the major culprits in many developed countries, stem and progenitor cell driven approaches may give the clinicians a new arsenal to tackle many significant health issues. However, stem and progenitor cell mediated cardiovascular regeneration can be achieved via complex and dynamic molecular mechanisms involving a variety of cells, growth factors, cytokines, and genes. Functional contributions of transplanted cells on target organs and their survival are still critical problems waiting to be resolved. Moreover, the regeneration of contracting myocardial tissue has controversial results in human trials. Thus, moderately favourable clinical results should be interpreted carefully. Determining the behavioural programs, genetic and transcriptional control of stem cells, mechanisms that determine cell fate, and functional characteristics are the primary targets. In addition, ensuring the long-term follow-up of cells with efficient imaging techniques in human clinical studies may provide a resurgence of the initial enthusiasm, which has faded over time. Here, we provide a brief historical perspective on stem cell driven cardiac regeneration and discuss cardiac and vascular repair in the context of translational science.
authors.affiliation: Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Turkey.
authors.forename: Serkan
authors.initials: S
authors.lastname: Durdu
authors.forename: Gunseli Cubukcuoglu
authors.initials: GC
authors.lastname: Deniz
authors.forename: Arin
authors.initials: A
authors.lastname: Dogan
authors.forename: Cagin
authors.initials: C
authors.lastname: Zaim
authors.forename: Aynur
authors.initials: A
authors.lastname: Karadag
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Dastouri
authors.forename: Ahmet Ruchan
authors.initials: AR
authors.lastname: Akar
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D032383:Myocytes, Cardiac / Q000637:transplantation; D018919:Neovascularization, Physiologic; D012038:Regeneration; D033581:Stem Cell Transplantation